- Home
- VTSI vs ABOS Comparison
VTSI vs ABOS Comparison
Compare VTSI & ABOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VTSI
- ABOS
- Stock Information
- Founded
- VTSI 1993
- ABOS 1996
- Country
- VTSI United States
- ABOS United States
- Employees
- VTSI N/A
- ABOS N/A
- Industry
- VTSI Miscellaneous manufacturing industries
- ABOS Biotechnology: Pharmaceutical Preparations
- Sector
- VTSI Consumer Discretionary
- ABOS Health Care
- Exchange
- VTSI Nasdaq
- ABOS Nasdaq
- Market Cap
- VTSI 67.3M
- ABOS 72.7M
- IPO Year
- VTSI N/A
- ABOS 2021
- Fundamental
- Price
- VTSI $6.47
- ABOS $1.18
- Analyst Decision
- VTSI Strong Buy
- ABOS Strong Buy
- Analyst Count
- VTSI 1
- ABOS 4
- Target Price
- VTSI $7.00
- ABOS $6.50
- AVG Volume (30 Days)
- VTSI 157.2K
- ABOS 571.8K
- Earning Date
- VTSI 08-11-2025
- ABOS 08-12-2025
- Dividend Yield
- VTSI N/A
- ABOS N/A
- EPS Growth
- VTSI N/A
- ABOS N/A
- EPS
- VTSI 0.19
- ABOS N/A
- Revenue
- VTSI $26,164,645.00
- ABOS N/A
- Revenue This Year
- VTSI $9.92
- ABOS N/A
- Revenue Next Year
- VTSI $16.54
- ABOS N/A
- P/E Ratio
- VTSI $37.29
- ABOS N/A
- Revenue Growth
- VTSI N/A
- ABOS N/A
- 52 Week Low
- VTSI $3.57
- ABOS $0.86
- 52 Week High
- VTSI $9.40
- ABOS $3.60
- Technical
- Relative Strength Index (RSI)
- VTSI 63.43
- ABOS 56.83
- Support Level
- VTSI $6.36
- ABOS $1.05
- Resistance Level
- VTSI $6.98
- ABOS $1.28
- Average True Range (ATR)
- VTSI 0.36
- ABOS 0.09
- MACD
- VTSI -0.01
- ABOS 0.01
- Stochastic Oscillator
- VTSI 72.11
- ABOS 61.54
About VTSI VirTra Inc.
VirTra Inc is a U.S.-based company that is engaged in the sale and development of the judgmental use of force training simulators and firearms training simulators for law enforcement, military, and commercial uses. It sells simulators and related products across the globe through a direct sales force and international distribution partners. The services provided by the company include installation, training, limited warranties, service agreements, and related support. The company sells and supports the use of force training and marksmanship firearms training systems and accessories for law enforcement, military, or civilian use. Company's The product lany includes simulators, upgrade components, scenarios, scenario software, recoil kits, Threat Fire, and other accessories.
About ABOS Acumen Pharmaceuticals Inc.
Acumen Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing a novel disease-modifying approach to target what it believes to be a key underlying cause of Alzheimer's disease. The company's drug candidate, ACU193, is a subclass monoclonal antibody that selectively targets amyloid-beta oligomers.